The Support for Cancer Clinical Trials program provides funding to Australia's 13 National Cancer Cooperative Trials Groups to build their capacity to undertake cancer clinical trials.
Clinical trials are fundamental to establishing whether new cancer treatments or new ways of using existing therapies, diagnostic tests, preventative or supportive interventions are effective and they help generate the evidence for best-practice cancer care.
Cancer Australia supports cancer clinical trials in Australia in the following ways:
- Supports the 13 National Cancer Trials Groups to develop industry-independent cancer clinical trials protocols.
- Funds the provision of National Technical Services to assist the National Cancer Cooperative Trials Groups to develop cancer clinical trials.
Cancer Australia is also undertaking specific work on increasing clinical trial information available to consumers.